A personalized vaccine demonstrated the potential to induce long-lasting immune response among people with advanced kidney ...

Researchers have developed a cancer vaccine method that can target virtually any solid tumor, amplifying the visibility of ...

Cash and cash equivalents at the end of fourth quarter of 2024 of approximately $60.0 million; secured up to €57.5 million in debt financing from the European Investment Bank (EIB); the company ...

Songwriter and music teacher Steve Young of Stevenage, Hertfordshire, made global news as one of the first people to be given ...

The concept of using vaccines to treat cancers has been around for several decades. A vaccine was first approved for prostate ...

Dr. Catherine Wu discussed the unique aspects of clear cell renal cell carcinoma and the challenges of targeting it with a ...

Part of that research is learning which cancers are better candidates for mRNA vaccines to be used as part of the treatment, Kamath said. Things like melanoma, which causes a lot of mutations in ...

Cancer vaccines harness the power of the immune system to stop tumors in their tracks. They work a little differently than ...

mRNA specialist BioNTech has chalked up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine candidate in a phase 2 trial in advanced melanoma. The study is looking at ...